Financhill
Back

PROCEPT BioRobotics Quote, Financials, Valuation and Earnings

Buy
89

PRCT
PROCEPT BioRobotics

Last Price:
68.16
Seasonality Move:
13.85%

7 Day Trial

ALL ACCESS PASS

$ 7

PROCEPT BioRobotics Price Quote

$68.16
+0.06 (+0.03%)
(Updated: May 18, 2024 at 5:51 AM ET)

PROCEPT BioRobotics Key Stats

Buy
89
PROCEPT BioRobotics (PRCT) is a Buy

Day range:
$67.44 - $68.84
52-week range:
$24.83 - $77.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.25
P/B ratio:
13.26%

Volume:
503K
Avg. volume:
664.9K
1-year change:
109.6%
Market cap:
$3.5B
Revenue:
$136.2M
EPS:
$-2.12

How Much Does PROCEPT BioRobotics Make?

Is PROCEPT BioRobotics Growing As A Company?

  • What Is PROCEPT BioRobotics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.83%
  • What Is PROCEPT BioRobotics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PROCEPT BioRobotics Stock Price Performance

What Is PROCEPT BioRobotics 52-Week High & Low?

PROCEPT BioRobotics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PROCEPT BioRobotics?

Is PROCEPT BioRobotics Cash Flow Positive?

  • What Is PRCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$104.4M
  • What Is PROCEPT BioRobotics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $170M
  • What Is PROCEPT BioRobotics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$21.8M

PROCEPT BioRobotics Return On Invested Capital

  • Is Management Doing A Good Job?
    PRCT return on invested capital is -36.15%
  • What Is PROCEPT BioRobotics Return On Assets?
    ROA measures how assets are converting to revenues and is -29.27%
  • What Is PRCT Return On Equity?
    ROE is a measure of profitability and is -44.06%

PROCEPT BioRobotics Earnings Date & Stock Price

PROCEPT BioRobotics Competitors

  • Who Are PROCEPT BioRobotics's Competitors?
    Below is a list of companies who compete with PROCEPT BioRobotics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Integra Lifesciences Holdings Corp (IART)
    • Intuitive Surgical Inc (ISRG)
    • Masimo Corp (MASI)
    • Xtant Medical Holdings Inc (XTNT)

PROCEPT BioRobotics Dividend Yield

Data Unavailable

PROCEPT BioRobotics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 9.74%
Revenue: 82.51% 6.89%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 70.83
Upside from Last Price: 4.01%

Major Shareholders

  • How many PRCT shares are owned by institutional investors?
    68.2M PRCT shares are owned by institutional investors
  • How many PRCT shares are owned by insiders?
    1.5M PRCT shares are owned by insiders